Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center

Imagem de Miniatura
Arquivos
art_MONTAGNINI_Adjuvant_chemoradiotherapy_after_d2_lymphadenectomy_for_gastric_cancer_2012.PDF (286.85 KB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
COSTA JR., Wilson L.
COIMBRA, Felipe J. F.
FOGAROLI, Ricardo C.
RIBEIRO, Heber S. C.
DINIZ, Alessandro L.
BEGNAMI, Maria Dirlei F. L.
MELLO, Celso A. L.
FANELLI, Marcelo F.
SILVA, Milton J. B.
FREGNANI, Jose Humberto
Citação
RADIATION ONCOLOGY, v.7, article ID 169, 9p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Adjuvant chemoradiotherapy is part of a multimodality treatment approach in order to improve survival outcomes after surgery for gastric cancer. The aims of this study are to describe the results of gastrectomy and adjuvant chemoradiotherapy in patients treated in a single institution, and to identify prognostic factors that could determine which individuals would benefit from this treatment. Methods: This retrospective study included patients with pathologically confirmed gastric adenocarcinoma who underwent surgical treatment with curative intent in a single cancer center in Brazil, between 1998 and 2008. Among 327 patients treated in this period, 142 were selected. Exclusion criteria were distant metastatic disease (M1), T1N0 tumors, different multimodality treatments and tumors of the gastric stump. Another 10 individuals were lost to follow-up and there were 3 postoperative deaths. The role of several clinical and pathological variables as prognostic factors was determined. Results: D2-lymphadenectomy was performed in 90.8% of the patients, who had 5-year overall and disease-free survival of 58.9% and 55.7%. The interaction of N-category and N-ratio, extended resection and perineural invasion were independent prognostic factors for overall and disease-free survival. Adjuvant chemoradiotherapy was not associated with a significant improvement in survival. Patients with node-positive disease had improved survival with adjuvant chemoradiotherapy, especially when we grouped patients with N1 and N2 tumors and a higher N-ratio. These individuals had worse disease-free (30.3% vs. 48.9%) and overall survival (30.9% vs. 71.4%). Conclusion: N-category and N-ratio interaction, perineural invasion and extended resections were prognostic factors for survival in gastric cancer patients treated with D2-lymphadenectomy, but adjuvant chemoradiotherapy was not. There may be some benefit with this treatment in patients with node-positive disease and higher N-ratio.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/1150
Referências
  1. Coimbra FJF, 2011, EJSO-EUR J SURG ONC, V37, P47, DOI 10.1016/j.ejso.2010.11.002
  2. Costa MLV, 2006, ANN SURG ONCOL, V13, P843, DOI 10.1245/ASO.2006.05.040
  3. D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15
  4. Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23
  5. Edwards P, 2004, BRIT J CANCER, V90, P1888, DOI 10.1038/sj.bjc.6601790
  6. Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1245/aso.2002.9.3.278
  7. Kim CY, 2009, ANN SURG ONCOL, V16, P1868, DOI 10.1245/s10434-009-0430-8
  8. Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005
  9. Knight Greg, 2013, Gastric Cancer, V16, P28, DOI 10.1007/s10120-012-0148-3
  10. Lee J, 2011, J CLIN ONCOL, V30, P268
  11. Li W, 2010, WORLD J GASTROENTERO, V16, P5621, DOI 10.3748/wjg.v16.i44.5621
  12. Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187
  13. Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1
  14. Muratore A, 2009, EJSO-EUR J SURG ONC, V35, P588, DOI 10.1016/j.ejso.2008.12.012
  15. Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252
  16. Sasako M, 2009, GASTRIC CANCER, V12, P10, DOI 10.1007/s10120-008-0465-8
  17. Scartozzi M, 2006, BRIT J CANCER, V95, P445, DOI 10.1038/sj.bjc.6603286
  18. Sobin LH, 2010, INT UNION CANC UICC, P73
  19. Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X
  20. Tsang WK, 2007, CLIN ONCOL-UK, V19, P333, DOI 10.1016/j.clon.2007.03.004
  21. Yoo CH, 2000, BRIT J SURG, V87, P236, DOI 10.1046/j.1365-2168.2000.01360.x
  22. Yoshinori N, 1993, ANN SURG, V218, P47

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros